Medicines

  1. Descovy (emtricitabine/tenofovir alafenamide)
    Descovy (emtricitabine/tenofovir alafenamide)
    by Gilead Sciences International Limited
    for HIV/AIDS
    €694.80
  2. Empliciti (elotuzumab)
    Empliciti (elotuzumab)
    by Bristol-Myers Squibb
    for Multiple Myeloma
    €1,299.76
  3. Fycompa (perampanel)
    Fycompa (perampanel)
    by Eisai Europe Ltd
    for Epilepsy
    €114.00
  4. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
    €2,808.00
  5. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
    €790.20
  6. Kevzara (sarilumab)
    Kevzara (sarilumab)
    by Sanofi - Aventis Groupe
    for Rheumatoid Arthritis
    €1,506.00
  7. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €3,066.00
  8. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
    €2,592.00
  9. Lonsurf (trifluridine/tipiracil)
    Lonsurf (trifluridine/tipiracil)
    by Les Laboratoires Servier
    for Colorectal Cancer
    €852.00
View as Grid List

Items 37-45 of 70

per page
Set Descending Direction